Key Stats for HLF Stock
- Price Change for HLF stock: +18.32%
- HLF Share Price as of Feb. 19: $19.57
- 52-Week High: $20.34
- HLF Stock Price Target: $14.25
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Herbalife (HLF) stock surged after the company reported fourth-quarter results that beat expectations. The company posted adjusted EPS of $0.45, according to Reuters, exceeding analyst forecasts.
Q4 net sales rose 6.3% year over year to $1.3 billion. Management said pricing actions across several regions helped support revenue despite currency headwinds.
Investor sentiment was further boosted by news of a high-profile strategic investment. Cristiano Ronaldo invested $7.5 million in Herbalife’s Pro2col™ technology and acquired a 10% equity stake.
The announcement followed Herbalife’s 2025 acquisition of Pro2col Health and Pruvit Ventures assets. These initiatives reflect a broader strategy to expand into personalized nutrition and digital health platforms.
The combination of an earnings beat and increased visibility from the investment helped drive the stock higher. HLF shares had traded near $13 late last year before rallying sharply in recent weeks.
Analysts currently have a mean price target of $14.25 for Herbalife stock. That target sits below the current share price following the recent rally.
Street estimates range from $9 on the low end to $25 on the high end. The wide dispersion reflects uncertainty around long-term growth and leverage.
See analysts’ growth forecasts and price targets for HLF stock (It’s free!) >>>
What the Market Is Telling Us About HLF Stock
The rally suggests investors are focused on near-term earnings stability rather than valuation. Herbalife remains highly profitable at the operating level.
LTM gross margins stand at 77.9%, while EBIT margins are 9.9%. Returns on invested capital remain strong at 29.4%, reflecting efficient operations.
However, the balance sheet remains leveraged. Herbalife carries $1.83 billion in net debt, equal to 2.7x EBITDA.
Forward revenue growth is expected to be modest at 3.4%, but EPS is projected to grow faster. Analysts forecast 19.5% forward EPS CAGR, driven by margin stability and lower costs.
The stock trades at 5.6x forward EBITDA and 7.9x forward earnings. Despite low multiples, valuation discounts reflect debt levels and limited revenue growth. Herbalife pays a small dividend yielding 0.2%, but cash returns remain constrained by leverage.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does HLF Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
